{"id":388797,"date":"2020-11-25T20:29:34","date_gmt":"2020-11-26T01:29:34","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=388797"},"modified":"2020-11-25T20:29:34","modified_gmt":"2020-11-26T01:29:34","slug":"sonoma-pharmaceuticals-inc-investors-company-investigated-by-the-portnoy-law-firm","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/sonoma-pharmaceuticals-inc-investors-company-investigated-by-the-portnoy-law-firm\/","title":{"rendered":"Sonoma Pharmaceuticals, Inc. Investors: Company Investigated by the Portnoy Law Firm"},"content":{"rendered":"

\nInvestors can contact the law firm at no cost to learn more about recovering their losses
\n<\/h2>\n
\n

LOS ANGELES, Nov. 25, 2020 (GLOBE NEWSWIRE) — The Portnoy Law Firm<\/u><\/a> advises Sonoma Pharmaceuticals, Inc. (“Sonoma” or the “Company”) (NASDAQ:SNOA) investors that the firm has initiated an investigation into possible securities fraud, and may file a class action on behalf of investors. The investigation focuses on news concerning the violation of securities laws.<\/p>\n

Investors are encouraged to contact attorney Lesley F. Portnoy<\/u><\/a>,\u00a0by phone 310-692-8883 or email<\/u><\/a>: lesley@portnoylaw.com, to discuss their legal rights, or click here<\/u><\/a> to join the case via www.portnoylaw.com<\/u><\/a>. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors\u2019 options for pursuing claims to recover their losses.<\/p>\n

The investigation focuses on whether Sonoma issued misleading and\/or false statements and\/or failed to disclose information pertinent to investors. An 8-K was filed by Sonoma with the SEC on November 17, 2020. The filing announced that the Sonoma\u2019s \u201cunaudited condensed consolidated interim financial statements for the quarter ended June 30, 2020 should no longer be relied upon.\u201d Sonoma added that the financial statements \u201ccontained material errors\u201d and that \u201cthe Company will need to restate them.\u201d Berry\u2019s shares fell by more than 14% on the next trading day, based on these facts.<\/p>\n

Please visit our website<\/u><\/a> to review more information and submit your transaction information.<\/p>\n

The Portnoy Law Firm represents investors in pursuing claims arising from corporate wrongdoing. The Firm\u2019s founding partner has recovered over $5.5 billion for aggrieved investors. Attorney advertising. Prior results do not guarantee similar outcomes.<\/p>\n

Lesley F. Portnoy, Esq.
Admitted CA and NY Bar
lesley@portnoylaw.com<\/u><\/a>
310-692-8883
www.portnoylaw.com<\/p>\n

Attorney Advertising<\/p>\n

\n
\n
\n \n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Nov. 25, 2020 (GLOBE NEWSWIRE) — The Portnoy Law Firm advises Sonoma Pharmaceuticals, Inc. (“Sonoma” or the “Company”) (NASDAQ:SNOA) investors that the firm has initiated an investigation into possible securities fraud, and may file a class action on behalf of investors. The investigation focuses on news concerning the violation of securities laws. Investors are encouraged to contact attorney Lesley F. Portnoy,\u00a0by phone 310-692-8883 or email: lesley@portnoylaw.com, to discuss their legal rights, or click here to join the case via www.portnoylaw.com. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors\u2019 options for pursuing claims to recover their losses. The … <\/p>\n

Continue reading “Sonoma Pharmaceuticals, Inc. Investors: Company Investigated by the Portnoy Law Firm”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-388797","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nSonoma Pharmaceuticals, Inc. Investors: Company Investigated by the Portnoy Law Firm - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/sonoma-pharmaceuticals-inc-investors-company-investigated-by-the-portnoy-law-firm\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Sonoma Pharmaceuticals, Inc. Investors: Company Investigated by the Portnoy Law Firm - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Nov. 25, 2020 (GLOBE NEWSWIRE) — The Portnoy Law Firm advises Sonoma Pharmaceuticals, Inc. (“Sonoma” or the “Company”) (NASDAQ:SNOA) investors that the firm has initiated an investigation into possible securities fraud, and may file a class action on behalf of investors. The investigation focuses on news concerning the violation of securities laws. Investors are encouraged to contact attorney Lesley F. Portnoy,\u00a0by phone 310-692-8883 or email: lesley@portnoylaw.com, to discuss their legal rights, or click here to join the case via www.portnoylaw.com. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors\u2019 options for pursuing claims to recover their losses. The … Continue reading "Sonoma Pharmaceuticals, Inc. Investors: Company Investigated by the Portnoy Law Firm"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/sonoma-pharmaceuticals-inc-investors-company-investigated-by-the-portnoy-law-firm\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-11-26T01:29:34+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5MjU1MCMzODQ0ODQxIzIxOTU1Mjc=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sonoma-pharmaceuticals-inc-investors-company-investigated-by-the-portnoy-law-firm\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sonoma-pharmaceuticals-inc-investors-company-investigated-by-the-portnoy-law-firm\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Sonoma Pharmaceuticals, Inc. Investors: Company Investigated by the Portnoy Law Firm\",\"datePublished\":\"2020-11-26T01:29:34+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sonoma-pharmaceuticals-inc-investors-company-investigated-by-the-portnoy-law-firm\\\/\"},\"wordCount\":291,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sonoma-pharmaceuticals-inc-investors-company-investigated-by-the-portnoy-law-firm\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA5MjU1MCMzODQ0ODQxIzIxOTU1Mjc=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sonoma-pharmaceuticals-inc-investors-company-investigated-by-the-portnoy-law-firm\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sonoma-pharmaceuticals-inc-investors-company-investigated-by-the-portnoy-law-firm\\\/\",\"name\":\"Sonoma Pharmaceuticals, Inc. Investors: Company Investigated by the Portnoy Law Firm - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sonoma-pharmaceuticals-inc-investors-company-investigated-by-the-portnoy-law-firm\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sonoma-pharmaceuticals-inc-investors-company-investigated-by-the-portnoy-law-firm\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA5MjU1MCMzODQ0ODQxIzIxOTU1Mjc=\",\"datePublished\":\"2020-11-26T01:29:34+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sonoma-pharmaceuticals-inc-investors-company-investigated-by-the-portnoy-law-firm\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sonoma-pharmaceuticals-inc-investors-company-investigated-by-the-portnoy-law-firm\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sonoma-pharmaceuticals-inc-investors-company-investigated-by-the-portnoy-law-firm\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA5MjU1MCMzODQ0ODQxIzIxOTU1Mjc=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA5MjU1MCMzODQ0ODQxIzIxOTU1Mjc=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sonoma-pharmaceuticals-inc-investors-company-investigated-by-the-portnoy-law-firm\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Sonoma Pharmaceuticals, Inc. Investors: Company Investigated by the Portnoy Law Firm\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Sonoma Pharmaceuticals, Inc. Investors: Company Investigated by the Portnoy Law Firm - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/sonoma-pharmaceuticals-inc-investors-company-investigated-by-the-portnoy-law-firm\/","og_locale":"en_US","og_type":"article","og_title":"Sonoma Pharmaceuticals, Inc. Investors: Company Investigated by the Portnoy Law Firm - Market Newsdesk","og_description":"Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Nov. 25, 2020 (GLOBE NEWSWIRE) — The Portnoy Law Firm advises Sonoma Pharmaceuticals, Inc. (“Sonoma” or the “Company”) (NASDAQ:SNOA) investors that the firm has initiated an investigation into possible securities fraud, and may file a class action on behalf of investors. The investigation focuses on news concerning the violation of securities laws. Investors are encouraged to contact attorney Lesley F. Portnoy,\u00a0by phone 310-692-8883 or email: lesley@portnoylaw.com, to discuss their legal rights, or click here to join the case via www.portnoylaw.com. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors\u2019 options for pursuing claims to recover their losses. The … Continue reading \"Sonoma Pharmaceuticals, Inc. Investors: Company Investigated by the Portnoy Law Firm\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/sonoma-pharmaceuticals-inc-investors-company-investigated-by-the-portnoy-law-firm\/","og_site_name":"Market Newsdesk","article_published_time":"2020-11-26T01:29:34+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5MjU1MCMzODQ0ODQxIzIxOTU1Mjc=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sonoma-pharmaceuticals-inc-investors-company-investigated-by-the-portnoy-law-firm\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sonoma-pharmaceuticals-inc-investors-company-investigated-by-the-portnoy-law-firm\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Sonoma Pharmaceuticals, Inc. Investors: Company Investigated by the Portnoy Law Firm","datePublished":"2020-11-26T01:29:34+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sonoma-pharmaceuticals-inc-investors-company-investigated-by-the-portnoy-law-firm\/"},"wordCount":291,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sonoma-pharmaceuticals-inc-investors-company-investigated-by-the-portnoy-law-firm\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5MjU1MCMzODQ0ODQxIzIxOTU1Mjc=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sonoma-pharmaceuticals-inc-investors-company-investigated-by-the-portnoy-law-firm\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/sonoma-pharmaceuticals-inc-investors-company-investigated-by-the-portnoy-law-firm\/","name":"Sonoma Pharmaceuticals, Inc. Investors: Company Investigated by the Portnoy Law Firm - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sonoma-pharmaceuticals-inc-investors-company-investigated-by-the-portnoy-law-firm\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sonoma-pharmaceuticals-inc-investors-company-investigated-by-the-portnoy-law-firm\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5MjU1MCMzODQ0ODQxIzIxOTU1Mjc=","datePublished":"2020-11-26T01:29:34+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sonoma-pharmaceuticals-inc-investors-company-investigated-by-the-portnoy-law-firm\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/sonoma-pharmaceuticals-inc-investors-company-investigated-by-the-portnoy-law-firm\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sonoma-pharmaceuticals-inc-investors-company-investigated-by-the-portnoy-law-firm\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5MjU1MCMzODQ0ODQxIzIxOTU1Mjc=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5MjU1MCMzODQ0ODQxIzIxOTU1Mjc="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sonoma-pharmaceuticals-inc-investors-company-investigated-by-the-portnoy-law-firm\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Sonoma Pharmaceuticals, Inc. Investors: Company Investigated by the Portnoy Law Firm"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/388797","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=388797"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/388797\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=388797"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=388797"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=388797"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}